Project Grant R01NS142318
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant totaling $521,839 to the University of California, San Diego on August 7, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This five-year research award, with a completion date of July 31, 2030, supports investigation into the mechanisms by which pathogenic microglial populations contribute to central...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $1,179,715 to The Regents of the University of California, San Francisco under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on March 15, 2026, for a Project Grant extending through January 31, 2034. The award supports fundamental research investigating pain mechanisms and nociception—the process by which specialized nerve fibers...
- Federal Grant Award Summary Florida International University received a $471,698 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on May 13, 2026, with a completion date of March 31, 2031. The award funds research investigating the novel role of perivascular fibroblasts in secondary injury following cervical spinal cord injury (SCI). The...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $198,928 to The Regents of the University of California, San Francisco under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on August 1, 2025, with completion scheduled for July 31, 2030. This Project Grant supports research aimed at elucidating the cellular mechanisms underlying multiple sclerosis (MS) progression, with a focus on...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the Regents of the University of Michigan a Project Grant totaling $531,478 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective August 1, 2025, through July 31, 2030, supports fundamental research investigating the immune metabolic mechanisms underlying peripheral nervous system (PNS) degeneration and regeneration...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $495,164 Project Grant to the University of California, Los Angeles (UCLA) effective June 1, 2026, through May 31, 2031, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The award funds integrated molecular and genetic research to elucidate the mechanisms governing Schwann cell development and plasticity in peripheral nerve regeneration....
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded UC San Diego a Project Grant of $438,625 on August 7, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award funds research investigating a novel neuronal pro-survival mechanism called "actinification," a reorganization of the neuronal actin cytoskeleton triggered by ischemic brain injury. The research...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the Regents of the University of California, San Francisco a $264,746 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective February 3, 2026, through January 31, 2031. The EXPanding Access to Neurosurgery reSearch Education (EXPANSE) program addresses a critical pipeline gap by providing medical students at...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Ohio State University a Project Grant of $586,866 on May 6, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award funds research to develop and validate a regenerative therapy for cervical spinal cord injury (SCI) through the transplantation of human induced pluripotent stem cell (iPSC)-derived deep cortical neurons....
- Federal Project Grant Award Summary The University of California, San Diego received a $572,114 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 15, 2025, with a completion date of June 30, 2030. This research project focuses on developing and validating a novel therapeutic device and methodology for peripheral nerve repair...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Regents of the University of California, San Francisco a Project Grant of $646,936 (obligated June 1, 2026) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This five-year research initiative, concluding May 31, 2031, investigates the inflammatory mechanisms underlying spinal cord dysfunction in polytraumatic spinal cord injury (SCI)—cases where SCI is accompanied by peripheral injuries such as fractures, lacerations, or skin abrasions. The research will employ multiple animal models of peripheral injury combined with contusive SCI, followed by targeted anti-inflammatory interventions, to elucidate how peripheral tissue damage exacerbates neuroinflammation and impairs recovery of locomotor and sensory function. The project will deliver scientific knowledge through three primary research objectives: determining the precise immunomodulatory mechanisms by which peripheral injury alters spinal cord function after SCI; assessing the contribution of peripheral circulating immune cells to central nervous system dysfunction; and evaluating whether general anti-inflammatory or targeted peripheral immune cell blockade can reduce neuroinflammation and improve behavioral recovery. Deliverables will include mechanistic data on neuroinflammatory pathways, comparative efficacy data for central versus systemic anti-inflammatory interventions, and evidence to support development of targeted therapeutic strategies for polytraumatic SCI patients.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $646.9k | 5/29/26 |